LOPEZ, OMAR D.,CHEN, QI,BELEMA, MAKONEN,HAMANN, LAWRENCE G.
申请号：
CA2758047
公开号：
CA2758047C
申请日:
2010.03.29
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
This disclosure concerns novel compounds of Formula (I) as defined in thespecificationand compositions comprising such novel compounds. These compounds arc usefulantiviralagents, especially in inhibiting the function of the NS5A protein encoded byHepatitis C virus(HCV). Thus, the disclosure also concerns a method of treating HCV relateddiseases orconditions by use of these novel compounds or a composition comprising suchnovelcompounds.(see formula I)
